Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage
Reexamination Certificate
2007-05-01
2007-05-01
Chen, Stacy B. (Department: 1648)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving virus or bacteriophage
C435S004000, C435S069100, C424S204100, C536S023720
Reexamination Certificate
active
10780318
ABSTRACT:
Provided is a method for reducing viral load of porcine circovirus type 2 (PCV-2) in a pig by inducing an immune response against PCV-2 through the administration of an immunogenic composition comprising a PCV-2 antigen. A preferred antigen is a vector containing a PCV-2 nucleotide sequence. In a particularly preferred embodiment, the PCV-2 nucleotide sequence is ORF4, ORF13, or ORF4 and ORF13. In some embodiments, the immunogenic composition includes one or more additional pig pathogens.
REFERENCES:
patent: 6207165 (2001-03-01), Audonnet et al.
patent: 6217883 (2001-04-01), Allan et al.
patent: 6368601 (2002-04-01), Allan et al.
patent: 6391314 (2002-05-01), Allan et al.
patent: 6497883 (2002-12-01), Bublot et al.
patent: 6703023 (2004-03-01), Jestin et al.
patent: 2772047 (1999-06-01), None
patent: 99/29717 (1999-06-01), None
patent: 99/29871 (1999-06-01), None
GenBank Accession No. AF027217; Dec. 17, 1997.
GenBank Accession No. AF027217; May 14, 1998.
Nayar et al., Canadian Veterinary Journal, vol. 38, Jun. 1997, pp. 385-386.
E.G. Clark, American Association of Swine Practioners, 1997, pp. 499-501.
Meehan et al., Journal of General Virology, vol. 78, 1997, pp. 221-227.
Todd et al., Arch. Virol., vol. 117, 1991, pp. 129-135.
Daft et al., 39thAnnual Meeting of American Association of Veterinary Laboratory Diagnosticians, Oct. 12-18, 1996.
Harding et al., American Association of Swine Practioners, 1997, p. 503.
Albina et al., La Semaine Veterinaire des Filieres, No. 26, Nov. 30, 1996, pp. 1-2.
V. Dedet, La Semaine Veterinaire, May 24, 1997, p. 54.
Allan et al., J. Vet. Diagn. Invest., vol. 10 (1998), pp. 3-10.
Ellis et al., Can. Vet. J., vol. 39, Jan. 1998, pp. 44-51.
Segales et al., Veterinary Record, Dec. 6, 1997, pp. 600-601.
Allan et al., Vet. Immunol. Immunopathol., vol. 43 (1994), pp. 357-371.
Allan et al., Vet. Micro., vol. 44 (1995), pp. 49-64.
Tischer et al., Arch. Virol., vol. 91 (1986), pp. 271-276.
Hamel et al., Database EMBL/Genbank/DDBJ, Sep. 26, 1997.
Krakowka et al. 2001. Vet. Pathology 38:31-42.
Allan et al. 2000. J. Vet Diagn. Invest. 12:3-14.
Cruse et al. 1995. Illustrated Dictionary of Immunology. CRC Press, Inc. pp. 156.
Allan et al. 2000. Veterinary Record 147(6): 170-171.
West et al. 1999. J. Vet. Diagn. Invest. 11:530-532.
Bantle, John A. et al. “Phase III Interlaboratory Study of FETAX Part 3. FETAX Validation using 12 Compounds with and without an Exogenous Metabolic Activation System,”Journal of Applied Toxicology, 19:447-472 (1999).
Fort, Douglas J. et al. “Evaluation of the Developmental Toxicity of Thalidomide Using Frog Embryo Teratogenesis Assay—Xenopus (FETAX): Biotransformation and Detoxification,”Teratogensis, Carcinogenesis, and Mutagenesis, 20:35-47 (2000).
Newport, John et al. “Major Developmental Transition in Early Xenopus Embryos: I. Characterization and Timing of Cellular Changes at the Midblastula Stage,”Cell, vol. 30:675-686 (1982).
Newport, John et al. “A Major Developmental Transition in Early Xenopus Embryos: II. Control of the Onset of Transcription,”Cell, vol. 30:657-696 (1962).
Nakakura, Norihiko et al. “Synthesis of Heterogeneous mRNA-like RNA and Low-Molecular-Weight RNA before the Midblastula Transition in Embryos ofXenopus laevis,” Developmental Biology, 123:421-429 (1987).
Adams, Mark D. et al. “Complementary DNA Sequencing: Expressed Sequence Tags and Human Genome Project,” 1651-1656. (1991).
Schena, Mark, et al. “Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray,”Science, vol. 270:467-470 (1995).
Schena, Mark et al. “Parallel human genome analysis: Microarray-based expression monitoring of 1000 genes,”Proc. Natl. Acad. Sci. USA, vol. 93:10614-10619 (1996).
Zhang, Michael Q. “Large-Scale Gene Expression Data Analysis: A New Challenge to Computational Biologists,”Cold Spring Harbor Laboratory, vol. 9, Issue 8:681-688 (1999).
Nuwaysir, Emile F. et al. “Microarrays and Toxicology: The Advent of Toxicogenomics,”Molecular Carcinogenesis, 24:153-159 (1999).
Altmann, Curtis R. et al. “Microarray-Based Analysis of Early Development inXenopus laevis,” Developmental Biology, 236:64-75 (2001).
Nieuwkoop and Faber (1967) External and Internal Stage Criteria in the Development ofXenopus laevis, Chapter VII, 162-188.
Allan Gordon Moore
Audonnet Jean-Christophe Francis
Chappuis Gilles Emile
Charreyre Catherine Elisabeth
Clark Edward
Chen Stacy B.
Frommer & Lawrence & Haug LLP
Merial SAS
Yvon Anne-Marie C.
LandOfFree
Prevention of myocarditis, abortion and intrauterine... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prevention of myocarditis, abortion and intrauterine..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prevention of myocarditis, abortion and intrauterine... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3735722